Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 8,848 shares at $12.01 ($106K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $106k ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 4,424 | $53K | 50.0% |
| 2 | $12.01 | 4,424 | $53K | 50.0% |
| Total | $12.01 avg | 8,848 | $106K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |